Company intelligence / Profile preview

ISOFLEX

San Francisco, CA, USA

Ownership: Private
Employees: ~25
Development stage: Other

Overview

ISOFLEX is a leading global supplier of stable and radioactive isotopes for use in medical, scientific, and industrial applications. The company provides a vast catalog of enriched stable isotopes, including Carbon-13, Oxygen-18, and various metal isotopes used in diagnostic imaging and research. In the healthcare sector, ISOFLEX supports the production of radiopharmaceuticals and provides essential precursors for PET and SPECT imaging. Headquartered in San Francisco, the company operates an extensive global supply chain to serve the nuclear medicine and life sciences communities. Their expertise extends to technical consulting and custom isotope enrichment services for specialized research needs.

Modalities: Radiopharmaceutical
Industry: Chemicals & Materials

Beyond the preview

Go deeper on ISOFLEX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISOFLEX.

Explore the full profile